RGLS
Commonwealth Equity Services’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,700
| Closed | -$18K | – | 4270 |
|
|
2024
Q4 | $18K | Buy |
11,700
+200
| +2% | +$308 | ﹤0.01% | 4050 |
|
|
2024
Q3 | $18K | Sell |
11,500
-6,500
| -36% | -$10.2K | ﹤0.01% | 4005 |
|
|
2024
Q2 | $32K | Hold |
18,000
| – | – | ﹤0.01% | 3932 |
|
|
2024
Q1 | $52K | Buy |
18,000
+500
| +3% | +$1.44K | ﹤0.01% | 3887 |
|
|
2023
Q4 | $22K | Hold |
17,500
| – | – | ﹤0.01% | 3813 |
|
|
2023
Q3 | $24K | Hold |
17,500
| – | – | ﹤0.01% | 3720 |
|
|
2023
Q2 | $26K | Hold |
17,500
| – | – | ﹤0.01% | 3729 |
|
|
2023
Q1 | $14 | Hold |
17,500
| – | – | ﹤0.01% | 3699 |
|
|
2022
Q4 | $23K | Sell |
17,500
-16,000
| -48% | -$21K | ﹤0.01% | 3589 |
|
|
2022
Q3 | $56K | Buy |
33,500
+11,500
| +52% | +$19.2K | ﹤0.01% | 3471 |
|
|
2022
Q2 | $45K | Sell |
22,000
-109,000
| -83% | -$223K | ﹤0.01% | 3502 |
|
|
2022
Q1 | $39K | Buy |
131,000
+12,000
| +10% | +$3.57K | ﹤0.01% | 3608 |
|
|
2021
Q4 | $37K | Buy |
119,000
+8,000
| +7% | +$2.49K | ﹤0.01% | 3561 |
|
|
2021
Q3 | $76K | Buy |
111,000
+31,000
| +39% | +$21.2K | ﹤0.01% | 3455 |
|
|
2021
Q2 | $65K | Buy |
80,000
+60,000
| +300% | +$48.8K | ﹤0.01% | 3442 |
|
|
2021
Q1 | $31K | Buy |
+20,000
| New | +$31K | ﹤0.01% | 3360 |
|